Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

PURPOSE: The safety and efficacy of the combined use of sorafenib and yttrium-90 resin microspheres (Y90 RMS) to treat advanced hepatocellular carcinoma (HCC) is not well established. We determined the incidence of adverse events with this combination therapy in patients with advanced HCC at our ins...

詳細記述

保存先:
書誌詳細
出版年:J Hepatocell Carcinoma
主要な著者: Mahvash, Armeen, Murthy, Ravi, Odisio, Bruno C, Raghav, Kanwal Pratap, Girard, Lauren, Cheung, Sheree, Nguyen, Van, Ensor, Joe, Gadani, Sameer, Elsayes, Khaled M, Abdel-Wahab, Reham, Hassan, Manal, Shalaby, Ahmed S, Yao, James C, Wallace, Michael J, Kaseb, Ahmed O
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2016
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994795/
https://ncbi.nlm.nih.gov/pubmed/27574586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S62261
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料